These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20442570)

  • 21. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system.
    't Hart BA; Amor S
    Curr Opin Neurol; 2003 Jun; 16(3):375-83. PubMed ID: 12858076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
    Grigoriadis N; Grigoriadis S; Polyzoidou E; Milonas I; Karussis D
    Clin Neurol Neurosurg; 2006 Mar; 108(3):241-4. PubMed ID: 16388896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis.
    Nakahara J; Aiso S; Suzuki N
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):325-33. PubMed ID: 20676785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytokines in MS lesion].
    Kato H; Suzumura A
    Nihon Rinsho; 2003 Aug; 61(8):1428-34. PubMed ID: 12962034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
    Jensen J; Krakauer M; Sellebjerg F
    Cytokine; 2005 Jan; 29(1):24-30. PubMed ID: 15579375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylthioadenosine reverses brain autoimmune disease.
    Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
    Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of neuroinflammation: the role of CXCL10 in lymphocyte infiltration during autoimmune encephalomyelitis.
    Klein RS
    J Cell Biochem; 2004 May; 92(2):213-22. PubMed ID: 15108349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
    J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D in the healthy and inflamed central nervous system: access and function.
    Smolders J; Moen SM; Damoiseaux J; Huitinga I; Holmøy T
    J Neurol Sci; 2011 Dec; 311(1-2):37-43. PubMed ID: 21862439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J
    Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Involvement of NK and NKT cells in the pathogenesis of multiple sclerosis].
    Yamamura T
    Nihon Rinsho; 2003 Aug; 61(8):1329-34. PubMed ID: 12962019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.